Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sara Pasquina Pascale"'
Autor:
Sara Pasquina Pascale, Roberta Nuccorini, Teresa Pierri, Roberta Di Mare, Lucia Fabio, Emilia Lerose, Maria Antonietta Merlino, Pietro Schiavo, Angela Amendola, Gino Brucoli, Maria Denise Caputo, Ida Chitarrelli, Michele Cimminiello, Sabrina Coluzzi, Nunzio Biagio Filardi, Angela Matturro, Domenico Vertone, Monica Poggiaspalla, Francesco Malaspina, Gerardo Musuraca, Gennaro Coralluzzo, Clara Mannarella, Clelia Musto, Angela Pia Bellettieri, Giovanni Martinelli, Claudio Cerchione, Michele Pizzuti
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionIn immunocompromised patients, SARS-CoV-2 mRNA vaccine has been used in Italy from the beginning of the vaccination campaign, but several studies have shown that the serological response of onco-hematological patients was reduced compared
Externí odkaz:
https://doaj.org/article/79e40f4c80ce4cc8b74c96a0135360da
Autor:
Antonella Maria Salvia, Flavia Cuviello, Sabrina Coluzzi, Roberta Nuccorini, Immacolata Attolico, Sara Pasquina Pascale, Faustino Bisaccia, Michele Pizzuti, Angela Ostuni
Publikováno v:
Hematology Reports, Vol 9, Iss 4 (2017)
Hematopoietic cells express ATP binding cassette (ABC) transporters in relation to different degrees of differentiation. One of the known multidrug resistance mechanisms in acute myeloid leukemia (AML) is the overexpression of efflux pumps belonging
Externí odkaz:
https://doaj.org/article/481acc9a37af46b99c720d5e0b9e0600
Autor:
Nicola Piccirillo, Paolo Corradini, Domenico Pastore, Roberta Nuccorini, Giorgina Specchia, Francesco Saraceni, Massimo Martino, Massimo Pini, Sarah Marktel, Andrea Mengarelli, Pietro Pioltelli, Giuseppe Milone, Francesco Zallio, Monica Poiani, Elvira Di Nardo, Saveria Capria, Sara Pasquina Pascale, Tiziana Moscato, Gianluca Gaidano, Immacolata Attolico, Pellegrino Musto, Paolo Perseghin, Francesco Merli, Lucia Farina, Luca Nassi, Martina Chiarucci, Simona Sica, Giuseppe Mele, Jacopo Olivieri, Francesco Lanza, Attilio Olivieri, Fabio Ciceri, Katia Codeluppi
Predicting mobilization failure before it starts may enable patient-tailored strategies. Although consensus criteria for predicted PM (pPM) are available, their predictive performance has never been measured on real data. We retrospectively collected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dce93f45679ec9d126e8d80ff9b36616
http://hdl.handle.net/2318/1657273
http://hdl.handle.net/2318/1657273
Autor:
Sara Pasquina Pascale, Massimo Martino, Giuseppe Milone, Maurizio Musso, Roberta Nuccorini, Pasquale Iacopino, Bernardo Rossini, Patrizia Tedeschi, Vincenzo Pavone, Elvira Di Nardo, Alessandra Crescimanno, Immacolata Attolico, Angelo Ostuni, Sabrina Coluzzi, Attilio Olivieri
Publikováno v:
Biology of Blood and Marrow Transplantation. 18:241-249
We evaluated the safety and efficacy of plerixafor, subsequent to disease-specific chemotherapy followed by granulocyte-colony stimulating factor (G-CSF), in 37 multiple myeloma (MM) or lymphoma patients, who were candidates for autologous stem cell
Autor:
Paola Bresciani, Francesco Onida, Roberta Nuccorini, Jacopo Olivieri, Enzo Pavone, Nicola Mordini, Pietro Leoni, Andrea Bacigalupo, Francesca Patriarca, Antonella Poloni, Michele Cimminiello, Roberta Fedele, Sabrina Coluzzi, Sara Pasquina Pascale, Fabrizio Pane, Paolo Corradini, Silvia Svegliati, Attilio Olivieri, Armando Gabrielli, Carmine Selleri
Forty adults aged 28 to 73 years were entered into a prospective trial of imatinib for the treatment of steroid-refractory chronic graft-versus-host disease (SR-cGVHD). After 6 months, intention-to-treat (ITT) analysis of 39 patients who received the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e27dc14a00cd6f69758766357145fe7
http://hdl.handle.net/11390/1049399
http://hdl.handle.net/11390/1049399
Autor:
Michele Pizzuti, Alberto Santagostino, Maria Antonietta Rizzo, Daniela Dragonetti, Maria Grazia Pietrafesa, Immacolata Attolico, Angela Amendola, Nunzio Filardi, Michele Cimminiello, Angela Matturro, Domenico Vertone, Roberta Nuccorini, sara Pasquina Pascale, Sabrina Coluzzi
Publikováno v:
Blood. 122:4798-4798
Over the last few years there has been increased interest in laboratory tests for thrombophilia. Testing is predominantly performed to identify asymptomatic individuals at risk for a first thrombosis or patients (pts) at risk of relapse. The results
Autor:
Giorgia Mancini, Roberta Fedele, Paolo Corradini, Jacopo Olivieri, Sonia Mammoliti, Sara Pasquina Pascale, Michele Cimminiello, Attilio Olivieri, Alessandro Rambaldi, Vincenzo Pavone, Francesco Onida, Ivana Latesoriere, Pietro Leoni, Roberta Nuccorini
Publikováno v:
Blood. 122:4608-4608
Chronic Graft versus Host Disease (cGvHD) is still the leading cause of late mortality in transplanted patients. Among the new drugs potentially useful in patients with steroid-refractory cGVHD (SR-cGVHD), the Tyrosine Kinase Inhibitor (TKI) Imatinib
Autor:
Roberta Nuccorini, Immacolata Attolico, Romina Penitente, Giuseppina Smaldore, Ida Chitarrelli, Michele Pizzuti, Sara Pasquina Pascale, Michele Cimminiello, Antonella Girardi, Sabrina Coluzzi, Angela Amendola, Enza Scavone, Angela Matturro, Nunzio Filardi, Domenico Vertone, Alberto Santagostino
Publikováno v:
Blood. 122:5314-5314
Monoclonal gammopathy of undetermined significance (MGUS) occurs in 3% of people older than 50 years and up to 10% in those older than 70; it is associated with a 1%/year risk of progression to Multiple Myeloma (MM). In recent years there have been i
Autor:
Immacolata Attolico, Sabrina Coluzzi, Domenico Vertone, Roberta Nuccorini, Cristiana Carniti, Angela Matturro, Nunzio Filardi, Pellegrino Musto, Angela Amendola, Vincenzo Pavone, Gaetano Palumbo, Alberto Fragasso, Giorgina Specchia, Michele Cimminiello, Paolo Corradini, Silvana Capalbo, Michele Pizzuti, Attilio Olivieri, Sara Pasquina Pascale
Publikováno v:
Blood. 120:4523-4523
Abstract 4523 Autologous Stem Cell Transplantation (ASCT) is still an option for eligible patients with Multiple Myeloma (MM). High-dose melphalan (HDM: 200mg/m∧2) is the recommended conditioning before ASCT, but synergistic effects of Bortezomib (
Autor:
Attilio Olivieri, Angela Amendola, Roberta Nuccorini, Giancarlo Discepoli, Michele Pizzuti, Sara Pasquina Pascale, Imma Attolico, Sabrina Coluzzi
Publikováno v:
Blood. 114:4394-4394
Abstract 4394 Therapy-related acute myeloid leukemia (AML) and myelodysplastic syndrome (t-AML/MDS) are common after alkylating agents. t-AML/MDS related to alkylating agents are associated with monosomies or deletions of the long arm of chromosomes